Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
30 participants
INTERVENTIONAL
2023-07-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Transcranial Magnetic Stimulation on Learning With Reward in Healthy Humans
NCT01260740
Neural Representations of Memory Transformation (MEM_TRANS)
NCT06862622
Modulation of Brain Oscillations Underlying Working Memory
NCT05923606
Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition
NCT00740701
The Role of Different Prefrontal Areas in Visual Metacognition
NCT04263766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active non-invasive brain stimulation during behavioral memory interference
Non-invasive brain stimulation with transcranial alternating current stimulation will be applied during a memory interference intervention.
Transcranial alternating current stimulation (tACS) combined with behavioral intervention
Transcranial alternating current stimulation (tACS) combined with behavioral intervention (memory interference).
Sham stimulation during behavioral memory interference
Inactive (sham) stimulation will be applied during a memory interference intervention.
Inactive (sham) stimulation combined with behavioral intervention
Inactive (sham) stimulation combined with behavioral intervention (memory interference)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial alternating current stimulation (tACS) combined with behavioral intervention
Transcranial alternating current stimulation (tACS) combined with behavioral intervention (memory interference).
Inactive (sham) stimulation combined with behavioral intervention
Inactive (sham) stimulation combined with behavioral intervention (memory interference)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No previous stroke, brain tumor, neurodegenerative disease, or trauma to the head
* Ability to give consent for study participation
* who have access to a personal computer with internet
Exclusion Criteria
* Inability to use all ten fingers to type on a standard computer keyboard
* Uncorrected vision, hindering perception of visual cues presented on a standard computer screen
* Medication use at the time of study that may interfere with learning or the effect of tACS, including but not limited to carbamazepine, flunarizine, sulpiride, rivastigmine, dextromethorphan;
* Neuromuscular disorders affecting hand and finger movements necessary for 10-finger keyboard typing
* Presence of neurological or psychiatric disorders
* Presence of scalp injury or disease
* Prior history of seizures
* Prior intracranial surgery
* Prior brain radiotherapy
* Prior history of intracranial tumor, intracranial infection, or cerebrovascular malformation
* Metal in head or neck
* Contraindications to MRI (such as severe claustrophobia, implanted medical devices)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kirstin-Friederike Heise, PhD
Role: PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00126392
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.